The agency said it intends to take steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies, including Hims & Hers and other compounding pharmacies, as similar alternatives to FDA-approved drugs. This led Hims & Hers to halt sales of certain, lower-cost, non-FDA-approved, copycat versions of drugs like Wegovy and Ozempic
Wise, MD is a board-certified facial plastic surgeon and hair restoration specialist in Wayne, NJ Hardik Doshi, MD is a hair restoration specialist and lead surgeon at Ample based in New York Jacob Beer, MD is a board-certified dermatologist in West Palm Beach, FL Tina Alster, MD is a board-certified dermatologist based in Washington, D.C
Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
10.1016/j.ecoenv.2022.114015 13 GuoY.ZhangN.ZhangD.RenQ.GanzT.LiuS.et al (2019)